Arsanis Inks $10M Series A
Biotech startup Arsanis has closed on $10 million in Series A financing from OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences. The three firms contributed equally in the round, Arsanis said in a release. The money will help Arsanis to continue development of treatments in the anti-microbial infectious disease area.
28 February 2011•4 mins read
